Effect of alcohol withdrawal on liver transaminase levels and markers of liver fibrosis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 16, Issue 11, 2001, Pages 1254-1259

  Campbell, Stewart ^a,d,e   Timms, Peter M ^b   Maxwell, Paul R ^b   Doherty, Elizabeth M ^c   Rahman, Mohammad Z ^c   Lean, Michael E J ^d   Danesh, Booth J ^a  

^a STOBHILL HOSPITAL   (United Kingdom)

^b NHS Greater Glasgow and Clyde Clinical Biochemistry Service   (United Kingdom)

^c RUCHILL HOSPITAL   (United Kingdom)

^d GLASGOW ROYAL INFIRMARY   (United Kingdom)

^e NONE   (United Kingdom)

Author keywords

Acetaminophen; Alcohol withdrawal; Alcoholic liver disease; Liver transaminases; Procollagen peptide; Tissue inhibitor of metalloproteinase 1

Indexed keywords

AMINOTRANSFERASE; BENZODIAZEPINE; COLLAGEN; LIVER ENZYME; PARACETAMOL; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; AGED; ALCOHOL WITHDRAWAL; ALCOHOLISM; ARTICLE; CLINICAL TRIAL; COLLAGEN DEGRADATION; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MARKER; FIBROGENESIS; FUNCTION TEST; HUMAN; LIVER CLEARANCE; LIVER DISEASE; LIVER FIBROSIS; LIVER FUNCTION; LIVER LEVEL; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL;

EID: 0035700314     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2001.02620.x     Document Type: Article

References (30)

1. Alcoholic hepatitis
2. Alcoholic hepatitis: Natural history and evaluation of prednisolone therapy
3. Delirium Tremens: Some clinico-chemical features
4. Delirium tremens in Copenhagen
5. Clinical and biochemical course of alcoholic liver disease following sudden discontinuation of alcoholic consumption
6. Delirium tremens and certain other acute sequels of alcohol abuse
7. Effects of alcohol on liver haemodynamics in the presence and absence of liver disease
8. Biochemical factors in alcoholic liver disease
9. Analysing connective tissue metabolites in human serum. Biochemical, physiological and methodological aspects
10. Predicting body composition by densitometry from simple anthropometric measurements
11. Assessment of alcohol withdrawal: The revised Clinical Institute Withdrawal Assessment for Alcohol scale (CIWA-Ar)
12. Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen
13. Serum assays for liver fibrosis
14. Radioimmunoassay for type III procollagen peptide and its application to human liver disease
15. Alteration in splanchnic blood flow after low and high doses of ethanol
16. Hepatic fibrosis-correlation of biochemical and morphologic investigations
17. The biosynthesis of collagen and its disorders (first of two parts)
18. Ultrastructural localisation of type III procollagen in baboon liver
19. Blood analysis for liver fibrosis
20. Serum procollagen type III peptide as a marker of hepatic fibrogenesis in alcoholic hepatitis
21. Aminoterminal propeptide of type III procollagen is cleared from the circulation by receptor mediated endocytosis in liver endothelial cells
22. Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1 (TIMP1): Implications for regulation of matrix degradation in the liver
23. Mammalian collagenase increases in early alcoholic liver disease and decreases with cirrhosis
24. Serum tissue inhibitors of metalloproteinases in patients with chronic liver disease and with hepatocellular carcinoma
25. Tissue inhibitor of metalloproteinase-1 in the liver of patients with chronic liver disease
26. Tissue inhibitor of metalloproteinase is increased in the serum of precirrhotic and cirrhotic alcoholic patients and can serve as a marker of fibrosis
27. Liver fibrosis in alcoholics. Detection by fab radioimmunoassay of serum procollagen III peptides
28. Serum procollagen type III N-terminal peptides and laminin P1 peptide in alcoholic liver disease
29. Liver hypermetabolism during alcohol withdrawal in humans